» Articles » PMID: 18421251

Cancer Stem Cells and Survival Pathways

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2008 Apr 19
PMID 18421251
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Gliomas and medulloblastomas are the most frequent malignant brain tumors in adult and children respectively. Although both tumors arise in the CNS, there is a significant difference in their therapeutic response. Medulloblastomas are relatively curable, while glioblastomas are basically incurable. During the last decade several reports have demonstrated the existence of cancer stem cells in brain tumors, their location and their response to treatment. We have recently described the therapeutic response of medulloblastomas to radiation in their native microenvironment, illustrating how p53 and Pi3K signaling pathways lead to the evasion of cell death by the nestin-expressing cells in the perivascular stem cell niche, even while the bulk of tumor succumbs to apoptosis.(1) It remains to be determined whether this mechanism of tumor resistance applies to the more complex stem-cell niche and tumor bulk of gliomas.

Citing Articles

Organization of self-advantageous niche by neural stem/progenitor cells during development via autocrine VEGF-A under hypoxia.

Kashiwagi T, Takazawa Y, Kagawa T, Taga T Inflamm Regen. 2023; 43(1):8.

PMID: 36726165 PMC: 9893632. DOI: 10.1186/s41232-022-00254-2.


Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma.

Akindona F, Frederico S, Hancock J, Gilbert M Front Oncol. 2022; 12:947634.

PMID: 36091174 PMC: 9454306. DOI: 10.3389/fonc.2022.947634.


Differentially expression and function of circular RNAs in ovarian cancer stem cells.

Sohn E J Ovarian Res. 2022; 15(1):97.

PMID: 35978436 PMC: 9382745. DOI: 10.1186/s13048-022-01014-z.


Nestin-Expressing Cells in the Lung: The Bad and the Good Parts.

Jaramillo-Rangel G, Chavez-Briones M, Ancer-Arellano A, Ortega-Martinez M Cells. 2021; 10(12).

PMID: 34943921 PMC: 8700449. DOI: 10.3390/cells10123413.


The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance.

Narayanan S, Wu Z, Wang J, Ma H, Acharekar N, Koya J Int J Biol Sci. 2021; 17(10):2652-2665.

PMID: 34326700 PMC: 8315011. DOI: 10.7150/ijbs.61229.